Barclays’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $690K | Buy |
|
|||||
|
2025
Q3 | $352K | Buy |
|
|||||
|
2025
Q2 | $390K | Buy |
|
|||||
|
2025
Q1 | $358K | Sell |
|
|||||
|
2024
Q4 | $888K | Buy |
|
|||||
|
2024
Q3 | $721K | Buy |
|
|||||
|
2024
Q2 | $207K | Sell |
|
|||||
|
2024
Q1 | $319K | Sell |
|
|||||
|
2023
Q4 | $479K | Buy |
|
|||||
|
2023
Q3 | $93.7K | Sell |
|
|||||
|
2023
Q2 | $97.5K | Sell |
|
|||||
|
2023
Q1 | $148K | Sell |
|
|||||
|
2022
Q4 | $146K | Buy |
|
|||||
|
2022
Q3 | $19K | Buy |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $16K | Buy |
|